RLAY
Relay Therapeutics Inc
Price:  
4.71 
USD
Volume:  
1,763,930.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLAY WACC - Weighted Average Cost of Capital

The WACC of Relay Therapeutics Inc (RLAY) is 6.4%.

The Cost of Equity of Relay Therapeutics Inc (RLAY) is 9.10%.
The Cost of Debt of Relay Therapeutics Inc (RLAY) is 5.00%.

Range Selected
Cost of equity 7.80% - 10.40% 9.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 7.0% 6.4%
WACC

RLAY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.86 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 7.0%
Selected WACC 6.4%